Literature DB >> 4295312

Measurement of human luteinizing hormone in plasma by radioimmunoassay.

D S Schalch, A F Parlow, R C Boon, S Reichlin.   

Abstract

The recent isolation of highly purified human pituitary luteinizing hormone (LH) has permitted the development of a sensitive and specific radioimmunoassay for this hormone in plasma. Results of this immunoassay system employing anti-LH serum agree closely with previous reports for the measurement of plasma LH in which immunoassays employing cross-reactive antisera to human chorionic gonadotropin were used. The immunoassay and bioassay of LH in several crude and partially purified pituitary and urinary extracts show acceptable agreement. The sensitivity of the LH immunoassay (0.2 mmug/ml) is adequate to measure LH levels in almost half of all prepuberal children and in all but a few normal adults. A small, but significant, rise in plasma LH level occurs at pubescence in both boys and girls. In women, plasma LH level varies with both age and the phase of the menstrual cycle. The mean LH concentration in nine normal women during the follicular phase (1.2 mmug/ml was found to be significantly higher than during the luteal phase (1.0 mmug/ml). At midcycle, the mean peak LH level was 10.2 mmug/ml. In a large group of normal women, the mean plasma LH concentration rose significantly at menopause to a level of 5.8 mmug/ml during the fifth decade and 10.5 mmug/ml during the seventh decade. A small, but significant, rise in plasma LH concentration also occurred in men from the third and fourth decades (0.7 mmug/ml to the seventh and eighth decades (1.7 mmug/ml). Both estrogen and testosterone suppress plasma LH levels, but marked variation in response exists. The immunoassay serves as a useful diagnostic tool in evaluating men with gonadal failure, amenorrheic women of reproductive age, and postmenopausal women suspected of hypopituitarism. From the half-time disappearance of LH-(131)I in plasma (mean 69 min) and the calculated volume of distribution (2.5-2.8 liters) it has been determined that approximately 30 mug of LH is secreted per day in men, and in women except at midcycle, at which time the release of LH is estimated to be 10-15 times this basal rate.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4295312      PMCID: PMC297212          DOI: 10.1172/JCI105762

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  EFFECT OF SYNTHETIC PROGESTINS ON PITUITARY GONADOTROPHIN EXCRETION.

Authors:  M L TAYMOR
Journal:  J Clin Endocrinol Metab       Date:  1964-08       Impact factor: 5.958

2.  FOLLICLE-STIMULATING HORMONE AND LUTEINIZING HORMONE CONTENT OF POOLED HUMAN MENOPAUSAL PLASMA AND OF SUBFRACTIONS PREPARED BY COHN METHODS 6 AND 9.

Authors:  J W MCARTHUR; H N ANTONIADES; L H LARSON; R B PENNELL; F M INGERSOLL; H ULFELDER
Journal:  J Clin Endocrinol Metab       Date:  1964-05       Impact factor: 5.958

3.  THE SEPARATION AND PURIFICATION OF HUMAN LUTEINIZING AND THYROTROPHIC HORMONES.

Authors:  A S HARTREE; W R BUTT; K E KIRKHAM
Journal:  J Endocrinol       Date:  1964-04       Impact factor: 4.286

4.  A SENSITIVE DOUBLE ANTIBODY IMMUNOASSAY FOR HUMAN GROWTH HORMONE IN PLASMA.

Authors:  D S SCHALCH; M L PARKER
Journal:  Nature       Date:  1964-09-12       Impact factor: 49.962

5.  SPECIES DIFFERENCES IN FOLLICLE-STIMULATING HORMONE AS REVEALED BY THE SLOPE IN THE STEELMAN-POHLEY ASSAY.

Authors:  A F PARLOW; L E REICHERT
Journal:  Endocrinology       Date:  1963-12       Impact factor: 4.736

6.  RADIOIMMUNOASSAY OF HUMAN PLASMA ACTH.

Authors:  R S YALOW; S M GLICK; J ROTH; S A BERSON
Journal:  J Clin Endocrinol Metab       Date:  1964-11       Impact factor: 5.958

7.  PITUITARY GONADOTROPIC INHIBITORY ACTIVITY OF VARIOUS STEROIDS IN OVARIECTOMIZED-INTACT FEMALE RATS IN PARABIOSIS.

Authors:  F A KINCL; A J BIRCH; R I DORFMAN
Journal:  Proc Soc Exp Biol Med       Date:  1964-11

8.  RECOVERY AND PARTIAL PURIFICATION OF FSH AND LH DURING THE PURIFICATION OF TSH FROM HUMAN PITUITARY GLANDS.

Authors:  A F PARLOW; P G CONDLIFFE; L E REICHERT; A E WILHELMI
Journal:  Endocrinology       Date:  1965-01       Impact factor: 4.736

9.  URINARY EXCRETION OF GONADOTROPHINS WITH PARTICULAR REFERENCE TO CHILDREN.

Authors:  W FITSCHEN; B E CLAYTON
Journal:  Arch Dis Child       Date:  1965-02       Impact factor: 3.791

10.  Purification of human thyrotrophin.

Authors:  P G CONDLIFFE
Journal:  Endocrinology       Date:  1963-06       Impact factor: 4.736

View more
  23 in total

1.  Editorial: Hormones and elderly testes.

Authors: 
Journal:  Br Med J       Date:  1975-07-05

2.  Hydatidiform mole metastasizing to the lung.

Authors:  P R Band; S R Masse; D W Reid; J B Dossetor
Journal:  Can Med Assoc J       Date:  1976-05-08       Impact factor: 8.262

3.  A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.

Authors:  Yanett Anaya; Douglas A Mata; Joseph Letourneau; Hakan Cakmak; Marcelle I Cedars; Mitchell P Rosen
Journal:  J Assist Reprod Genet       Date:  2017-10-30       Impact factor: 3.412

Review 4.  Pituitary-gonadal axis: historical notes.

Authors:  J Lindholm; E Husted Nielsen
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 5.  Gonadotropins: present concepts in the human.

Authors:  R S Swerdloff; W D Odell
Journal:  Calif Med       Date:  1968-12

6.  Hypogonadotrophic hypogonadism in hemochromatosis.

Authors:  J R Kent; W S Aronow; L Meister
Journal:  Calif Med       Date:  1969-12

7.  Hormonal control of Leydig cell differentiation.

Authors:  A Aoki
Journal:  Protoplasma       Date:  1970       Impact factor: 3.356

Review 8.  New discoveries on the biology and detection of human chorionic gonadotropin.

Authors:  Laurence A Cole
Journal:  Reprod Biol Endocrinol       Date:  2009-01-26       Impact factor: 5.211

9.  Studies on the metabolic clearance rate and production rate of human luteinizing hormone and on the initial half-time of its subunits in man.

Authors:  R J Pepperell; D M Kretser; H G Burger
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

10.  Metabolic and renal clearance rates of purified human chorionic gonadotropin.

Authors:  R E Wehmann; B C Nisula
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.